ClinVar Miner

Submissions for variant NM_004304.5(ALK):c.1100C>G (p.Pro367Arg)

gnomAD frequency: 0.00023  dbSNP: rs144030155
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000460983 SCV000541876 uncertain significance Neuroblastoma, susceptibility to, 3 2024-01-27 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 367 of the ALK protein (p.Pro367Arg). This variant is present in population databases (rs144030155, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ALK-related conditions. ClinVar contains an entry for this variant (Variation ID: 133482). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
St. Jude Molecular Pathology, St. Jude Children's Research Hospital RCV000460983 SCV002526059 uncertain significance Neuroblastoma, susceptibility to, 3 2023-05-23 criteria provided, single submitter clinical testing The ALK c.1100C>G (p.Pro367Arg) missense change has a maximum subpopulation frequency of 0.022% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). The in silico tool REVEL predicts a benign effect on protein function, but to our knowledge this prediction has not been confirmed by functional studies. To our knowledge, this variant has not been reported in individuals with ALK-related neuroblastic tumor susceptibility. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance.
Sema4, Sema4 RCV002256051 SCV002528377 likely benign Hereditary cancer-predisposing syndrome 2021-06-13 criteria provided, single submitter curation
GeneDx RCV003223611 SCV003919606 likely benign not provided 2023-04-18 criteria provided, single submitter clinical testing See Variant Classification Assertion Criteria.
ITMI RCV000119986 SCV000084116 not provided not specified 2013-09-19 no assertion provided reference population

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.